Lonafarnib
Zokinvy (lonafarnib) is a prescription oral capsule medication that acts as a farnesyltransferase inhibitor. It comes in 50mg and 75mg strengths and is manufactured by Sentynl Therapeutics, Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Zokinvy (lonafarnib) is a prescription oral capsule medication that acts as a farnesyltransferase inhibitor. It comes in 50mg and 75mg strengths and is manufactured by Sentynl Therapeutics, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Lonafarnib",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Lonafarnib — ANDA 213969 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213969"
}
]
|
| identifier | ANDA213969 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"health-care",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Lonafarnib |
